Insider Ledger

ASND insider buying and SEC filings, explained

Ascendis Pharma A/S · CIK 1612042

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$777K
Insiders who bought
2
Sold (not marked 10b5-1)
$4.7M
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Sep 2, 2026SaleLars Holtug (Director) sold 236 shares at $264.13 ($62K). Holdings down 6% to 4,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Sep 3, 2026
Aug 14, 2026Purchase (code P)Jean Jacques Bienaime (Director) bought 2,000 shares at about $246.33 ($493K), reported as a purchase (code P). Holdings up 222% to 2,900 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 18, 2026
Jun 2, 2026Purchase (code P)Scott Thomas Smith (CFO) bought 100 shares at $219.00 ($22K), reported as a purchase (code P). Holdings up 2% to 4,367 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 2, 2026
May 29, 2026Purchase (code P)Jean Jacques Bienaime (Director) bought 500 shares at about $223.12 ($112K), reported as a purchase (code P). Holdings up 125% to 900 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 1, 2026
May 29, 2026Purchase (code P)Scott Thomas Smith (CFO) bought 250 shares at $223.32 ($56K), reported as a purchase (code P). Holdings up 6% to 4,267 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Jun 1, 2026
May 26, 2026Purchase (code P)Jean Jacques Bienaime (Director) bought 400 shares at about $237.81 ($95K), reported as a purchase (code P). New position of 400 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 27, 2026
May 11, 2026SaleFlemming Steen Jensen (Officer) sold 19,460 shares at $238.49 ($4.6M). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed May 12, 2026

3 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

2 insiders bought in 30 days

$284K in purchases since May 26, 2026 · Purchases traded May 26, 2026 to Jun 2, 2026 · Closed

InsiderValueTradedSource
Jean Jacques Bienaime (Director)$95KMay 26, 2026SEC filing
Scott Thomas Smith (CFO)$56KMay 29, 2026SEC filing
Jean Jacques Bienaime (Director)$112KMay 29, 2026SEC filing
Scott Thomas Smith (CFO)$22KJun 2, 2026SEC filing

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow ASND in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app